Wire · opportunities
Could Deep Brain Stimulation Help Treat Schizophrenia?
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 25 August 2026 · Fusion42 review
Deep brain stimulation (DBS) has received FDA conditional approval for an early feasibility study treating treatment-resistant schizophrenia (TRS) and schizoaffective disorder (SAD), aiming to alleviate persistent symptoms where antipsychotics fall short. Initial results from ongoing clinical trials show promising reductions in auditory hallucinations, though DBS remains experimental with a need for larger safety and efficacy studies.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
You building treatments for schizophrenia face a chance to pioneer a new approach beyond drugs. Clinical trials just opened a door to use implanted brain devices, creating a rare opportunity to reshape mental health care for treatment-resistant patients.
◆ Coverage
1 source · 24 Aug 2026
◆ Related on Wire
◆ Topics